Parvej Ahmad

About

I'm currently working in the Department of Biosciences, Integral University as a research scholar in the field of Cardiovascular Pharmacology & Biochemistry. The main focus of our research is to Target HMG-R, LDL, and LDL-receptor to manage the elevated level of Cholesterol via suitable and effective Natural products with no or less side-effect to humans.

Employment

• Sanjay Gandhi Post Graduate Institute of Medical Sciences Project Research Scientist
  2026 - Present
• Sanjay Gandhi Post Graduate Institute of Medical Sciences Research Associate-I
  2025 - 2026
• Sanjay Gandhi Post Graduate Institute of Medical Sciences Project Associate-I
  2023 - 2025

Education

• Integral University Ph. D.
  2017 - Present
• Integral University M.Sc. Microbiology
  2015 - 2017
• Integral University B.Sc. (Hons) Biotechnology
  2012 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Repurposing of FDA-approved Drugs Identifies Glipizide as a Potent HMG-CoA Reductase Inhibitor: a High-Throughput Virtual Screening and Molecular Dynamics Approach for Targeting Hypercholesterolemia
  Journal of Pharmaceutical Innovation 2026 DOI: 10.1007/s12247-025-10349-1
  +Save
• Prognostic significance and interplay of circulatory PCSK-9-ApoCIII-chemokine axis in type 2 diabetes and its complications: a pilot study in North Indian patients
  The Egyptian Journal of Internal Medicine 2026 DOI: 10.1186/S43162-026-00624-Z
  +Save
• Bromelain: Targeting dental biofilm through dual approach of protein interaction and in vitro validation
  Journal of Integrated Science and Technology 2025 DOI: 10.62110/sciencein.jist.2025.v13.1179
  +Save
• Targeting SARS-CoV-2 main protease (Mpro) and human ACE-2: A virtual screening of carotenoids and polyphenols from tomato (Solanum lycopersicum L.) to combat Covid-19
  Intelligent Pharmacy 2024 DOI: 10.1016/j.ipha.2023.10.008
  +Save
• A molecular informatics and in-vitro approach to evaluate the HMG-CoA reductase inhibitory efficacy of monoterpenes, carvacrol and geraniol
  Journal of Taibah University Medical Sciences 2024 DOI: 10.1080/16583655.2023.2297456
  +Save
• Organosulfur Compounds, S-Allyl-L-Cysteine and S-Ethyl-L-Cysteine, Target PCSK-9/LDL-R-Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet-Induced Metabolic Syndrome in Rats
  Phytotherapy Research 2024 DOI: 10.1002/PTR.8323
  +Save
• Naturally occurring organosulfur compounds effectively inhibits PCSK-9 activity and restrict PCSK-9-LDL-receptor interaction via in-silico and in-vitro approach
  Natural Product Research 2023 DOI: 10.1080/14786419.2023.2269465
  +Save
• Antioxidant, LC-MS Analysis, and Cholinesterase Inhibitory Potentials of Phoenix dactylifera Cultivar Khudari: An In Vitro Enzyme Kinetics and In Silico Study
  Biomolecules 2023 DOI: 10.3390/BIOM13101474
  +Save
• Target-Based Virtual and Biochemical Screening Against HMG-CoA Reductase Reveals Allium sativum-Derived Organosulfur Compound N-Acetyl Cysteine as a Cardioprotective Agent
  Revista Brasileira de Farmacognosia 2022 DOI: 10.1007/s43450-022-00330-1
  +Save
• Identification and evaluation of natural organosulfur compounds as potential dual inhibitors of α-amylase and α-glucosidase activity: an in-silico and in-vitro approach
  Medicinal Chemistry Research 2021 DOI: 10.1007/s00044-021-02799-2
  +Save